Parallax Volatility Advisers, L.P. Neogenomics Inc Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $38,195 - $67,849	3,273 New	3,273 $52,000
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $154,387 - $190,124	-7,889 Reduced 99.86%	11 $0
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $64,560 - $108,806	5,318 Added 205.96%	7,900 $162,000
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $29,021 - $47,767	2,582 New	2,582 $33,000
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $7,830 - $13,769	-980 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $53,950 - $65,367	-7,462 Reduced 88.39%	980 $8,000
Q4 2017 Feb 14, 2018	BUY	$8.02 - $11.18 $67,704 - $94,381	8,442	8,442 $75,000

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.